# US 2011/0092613 A1 · Materials formable in situ within a medical device

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2011/0092613 A1
- Document ID: US20110092613A1
- Status: Published application
- Kind: A1
- Application number: 12/970,515
- Filed: 2010-12-16
- Published: 2011-04-21
- Earliest claimed: 2006-05-30
- Assignees: Incept, LLC
- Inventors: Farhad Khosravi; James Dreher
- Web page: https://patentgrep.com/patent/US20110092613A1

## CPC

- A61L 24/046: {obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds (A61L24/043 takes precedence)}
- A61P 9/10: for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A61F 2/07: Stent-grafts
- Y10S 623/926: Synthetic
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- Y10S: TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS

## Abstract

Certain embodiments of the invention include forming a material in situ by introducing into a space within a patient a water soluble polymer precursor of at least about 10,000 molecular weight solubilized in a flowable aqueous solution. Functional groups on the polymer precursor undergo covalent bonding in situ to form a solid and nonbiodegradable material having a swellability less than about 20% v/v and a Young's modulus of at least about 100 kPa within about 30 seconds to about 30 minutes of initiating a chemical reaction of the functional groups to form the solid material.

## Claims

### Claim 1

A method of forming a material in situ comprising:
introducing into a space within a patient a water soluble polymer precursor of at least about 400 molecular weight solubilized in a flowable aqueous solution, wherein functional groups on the polymer precursor undergo covalent bonding to form a solid and nonbiodegradable material having a swellability less than about 20% v/v and a Young's modulus of at least about 100 kiloPascals within about 30 seconds to about 30 minutes of initiating a chemical reaction of the functional groups to form the solid material.

### Claim 2 (depends on 1)

The method of claim 1 wherein the polymeric precursor comprises at least 100 MW of polyethylene oxide.

### Claim 3 (depends on 1)

The method of claim 1 wherein the functional group comprises an acrylate.

### Claim 4 (depends on 1)

The method of claim 1 wherein the viscosity of the flowable solution is less than about 100 cp.

### Claim 5 (depends on 1)

The method of claim 1 wherein the functional groups are of a first type and further comprising a second type of functional groups on a second polymeric precursor that react to form covalent bonds with the first type of functional groups.

### Claim 6 (depends on 5)

The method of claim 5 wherein the first polymeric precursor has a molecular weight of at least about 10,000 and the second polymeric precursor has a molecular weight of less than about 3000.

### Claim 7 (depends on 1)

The method of claim 1 wherein initiating the chemical reaction comprises mixing the polymeric precursor with a polymerization initiator.

### Claim 8 (depends on 1)

The method of claim 1 wherein the solution further comprises a radio-opaque agent for imaging the material.

### Claim 9 (depends on 1)

The method of claim 1 wherein the functional groups are electrophilic or nucleophilic.

### Claim 10 (depends on 1)

The method of claim 1 wherein the functional groups are polymerizable by free radical polymerization.

### Claim 11 (depends on 1)

The method of claim 1 wherein the material has a Young's modulus of at least 10 kPa within 30 seconds to 10 minutes of initiating the chemical reaction of the functional groups.

### Claim 12 (depends on 1)

The method of claim 1 wherein the expandable member comprises a balloon or a cuff.

### Claim 13 (depends on 1)

The method of claim 1 wherein the polymeric precursor is present at a range of between about 0.1 parts to about 10 parts by weight of polymeric precursor compared to the weight of the aqueous solvent in the solution.

### Claim 14

A medical device comprising an expandable member that comprises an aqueous buffered solution and a solid and nonbiodegradable polymeric material having a Young's modulus of at least about 100 kiloPascals and a swellability of less. than about 20% v/v, wherein the aqueous buffered solution is dispersed through the material or partially partitioned from the material.

### Claim 15 (depends on 14)

The device of claim 14 wherein the aqueous solution is present at a range of between about 0.1 parts to about 1 part by weight of polymeric precursor compared to the weight of the aqueous solvent.

### Claim 16 (depends on 14)

The device of claim 14 wherein the material comprises polymers comprising 100 MW of polyethylene oxide.

### Claim 17 (depends on 14)

The device of claim 14 wherein the material comprises polyacrylate.

### Claim 18 (depends on 14)

The device of claim 14 wherein the material comprises a reaction product of two types of functional groups.

### Claim 19 (depends on 14)

The device of claim 14 wherein the material comprises a first polymer segment having a molecular weight of at least about 10,0000 and a second polymer segment having a molecular weight of less than about 1000.

### Claim 20 (depends on 14)

The device of claim 14 further comprising a radio-opaque agent for imaging the material.

### Claim 21 (depends on 14)

The device of claim 14 wherein the expandable member comprises a balloon or cuff.

### Claim 22

A method of forming a material in situ in a biocompatible expandable member comprising:
increasing a volume of an expandable member of a medical device within a patient by delivering a water soluble polymer precursor in a flowable aqueous solution into the expandable member, wherein functional groups on the polymer precursor undergo covalent bonding to form a solid and substantially non biodegradable material having a swellability of less than about 20% v/v and a Young's modulus of at least about 100 kiloPascals within about 30 seconds to about 30 minutes of initiating a chemical reaction of the functional groups to form the solid material.

### Claim 23 (depends on 22)

The method of claim 22 wherein the expandable member comprises a balloon or cuff.

### Claim 24 (depends on 22)

The method of claim 22 wherein the polymeric precursor is present at a range of between about 0.1 parts to about 10 parts by weight of polymeric precursor compared to the weight of the aqueous solvent in the solution.
